Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disabilities.

Early diagnosis and treatment are crucial for skin emergencies and drug reactions.

JAK inhibitors effectively treat certain skin diseases but need careful use due to potential safety concerns.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

AMFIBHA scaffold significantly healed large full-thickness burn wounds in rabbits and restored skin's mechanical properties.

Laser therapy helps relieve pain and improve life quality in small animals with osteoarthritis.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

New therapies for rare skin diseases show promise but need more research.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Photobiomodulation may help reduce pain and inflammation in knee osteoarthritis, but its long-term benefits are unclear.